These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25388867)

  • 1. In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy.
    Ferreira PF; Kilner PJ; McGill LA; Nielles-Vallespin S; Scott AD; Ho SY; McCarthy KP; Haba MM; Ismail TF; Gatehouse PD; de Silva R; Lyon AR; Prasad SK; Firmin DN; Pennell DJ
    J Cardiovasc Magn Reson; 2014 Nov; 16(1):87. PubMed ID: 25388867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.
    Das A; Kelly C; Teh I; Nguyen C; Brown LAE; Chowdhary A; Jex N; Thirunavukarasu S; Sharrack N; Gorecka M; Swoboda PP; Greenwood JP; Kellman P; Moon JC; Davies RH; Lopes LR; Joy G; Plein S; Schneider JE; Dall'Armellina E
    Eur Heart J Cardiovasc Imaging; 2022 Feb; 23(3):352-362. PubMed ID: 34694365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    McGill LA; Ismail TF; Nielles-Vallespin S; Ferreira P; Scott AD; Roughton M; Kilner PJ; Ho SY; McCarthy KP; Gatehouse PD; de Silva R; Speier P; Feiweier T; Mekkaoui C; Sosnovik DE; Prasad SK; Firmin DN; Pennell DJ
    J Cardiovasc Magn Reson; 2012 Dec; 14(1):86. PubMed ID: 23259835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance.
    Nielles-Vallespin S; Khalique Z; Ferreira PF; de Silva R; Scott AD; Kilner P; McGill LA; Giannakidis A; Gatehouse PD; Ennis D; Aliotta E; Al-Khalil M; Kellman P; Mazilu D; Balaban RS; Firmin DN; Arai AE; Pennell DJ
    J Am Coll Cardiol; 2017 Feb; 69(6):661-676. PubMed ID: 28183509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying Dynamic Myofiber Aggregate Reorientation in Dilated Cardiomyopathy Using In Vivo Magnetic Resonance Diffusion Tensor Imaging.
    von Deuster C; Sammut E; Asner L; Nordsletten D; Lamata P; Stoeck CT; Kozerke S; Razavi R
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):e005018. PubMed ID: 27729361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
    Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
    J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
    Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing dynamic myocardial microstructure with cardiac magnetic resonance diffusion tensor imaging.
    Axel L; Wedeen VJ; Ennis DB
    J Cardiovasc Magn Reson; 2014 Nov; 16(1):89. PubMed ID: 25388937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
    Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy.
    Satriano A; Heydari B; Guron N; Fenwick K; Cheung M; Mikami Y; Merchant N; Lydell CP; Howarth AG; Fine NM; White JA
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1913-1924. PubMed ID: 31144257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight Into Myocardial Microstructure of Athletes and Hypertrophic Cardiomyopathy Patients Using Diffusion Tensor Imaging.
    Das A; Chowdhary A; Kelly C; Teh I; Stoeck CT; Kozerke S; Maxwell N; Craven TP; Jex NJ; Saunderson CED; Brown LAE; Ben-Arzi H; Sengupta A; Page SP; Swoboda PP; Greenwood JP; Schneider JE; Plein S; Dall'Armellina E
    J Magn Reson Imaging; 2021 Jan; 53(1):73-82. PubMed ID: 32558016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.
    Brouwer WP; Baars EN; Germans T; de Boer K; Beek AM; van der Velden J; van Rossum AC; Hofman MB
    J Cardiovasc Magn Reson; 2014 Apr; 16(1):28. PubMed ID: 24766828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing cardiomyocyte mobility with multi-phase cardiac diffusion tensor MRI.
    Moulin K; Verzhbinsky IA; Maforo NG; Perotti LE; Ennis DB
    PLoS One; 2020; 15(11):e0241996. PubMed ID: 33180823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.